|
1. BIOLOGIE
|
|
|
Cell culture shock – a scientist’s hunt for the perfect cocktail [Cancer Research UK]
|
|
|
|
|
|
What’s the best food to give to cells in a lab to make them grow and behave like the cells in our body? Or, put another way, what should cell culture media be made from? Dr Saverio Tardito, from the Cancer Research UK Beatson Institute in Glasgow, has been pondering this question. And it’s led to him developing a new cocktail called Plasmax™ which he believes helps his cells in the lab to behave more naturally.
|
|
|
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
4.12 BIOPSIES LIQUIDES
|
|
|
|
How to catch ovarian cancer earlier [EurekAlert!]
|
|
|
|
|
|
The researchers used proteomics to search for signatures of cancer in uterine fluid. They compared samples from women with ovarian cancer having surgery in the course of treatment and from volunteers who had gynecological surgery for reasons unrelated to cancer, such as uterine fibroids or excessive bleeding.
|
|
|
|
|
|
|
4.9 DÉP., DIAG. & PRONO. - SEIN
|
|
|
|
5. TRAITEMENTS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
|
5.12.3 IMMUNOTHÉRAPIES-COMBINAISONS
|
|
|
Cold Genesys bags $22M to push oncolytic virus for bladder cancer [Fierce Biotech]
|
|
|
|
|
|
The company is testing the oncolytic immunotherapy CG0070 in combination with Merck’s Keytruda, in addition to as a monotherapy for non-muscle invasive bladder cancer (NMIBC). It’s also doing preclinical work combining the treatment with an undisclosed immune checkpoint modulator in muscle-invasive bladder cancer and other solid tumors.
|
|
|
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
5.2 PHARMA
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
Drug shortages jeopardize the lives of children with cancer [STAT]
|
|
|
|
|
|
We cannot continue to overlook the economic drivers that lead to shortages of older drugs costing just dollars per dose that offer cures for cancer while newer chemotherapy agents costing hundreds of thousands of dollars that may prolong life by just a few months are rarely, if ever, in short supply. Where is the logic?
|
|
|
|
|
|
|
6. LUTTE CONTRE LES CANCERS
|
|
|
|
Precision Medicine for Pediatric Cancer [Children's Hospital Los Angeles]
|
|
|
|
|
|
In a perspectives article published in the prestigious journal Science, Dr. Jaclyn Biegel, from Children’s Hospital Los Angeles, and Dr. Alejandro Sweet-Cordero, of the University of California, San Francisco, survey the landscape of this young field and present opportunities for using genomic information to advance a new era of care for children with cancer.
|
|
|
|
|
|
|
|
6.1 OBSERVATION
|
|
|
|
|
|
6.5 MÉDECINES ALTERNATIVES/COMPLÉMENTAIRES
|
|
|
|
6.7.3 DMP
|
|
|
|
|
6.9 CONTROVERSES
|
|
|
The rise and fall of scientific authority — and how to bring it back [Nature]
|
|
|
|
|
|
Preaching, denouncing or shouting ‘Science works!’ won’t help. Neither will throwing around statistics, graphs and charts. The best approach, in my view, is to examine the experiences of early proponents of scientific authority who faced powerful resistance, risked their careers and even lives, and had to develop countermeasures.
|
|
|
|
|
|